We serve Chemical Name:4-nitro-1H-pyrazol-5-amine CAS:16115-82-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-nitro-1H-pyrazol-5-amine
CAS.NO:16115-82-5
Synonyms:3(5)-Amino-4-nitro-pyrazol;4-Nitro-5-amino-pyrazol;3-Amino-4-nitropyrazole;3(5)-amino-4-nitropyrazole;4-nitropyrazole-5-ylamine;4-nitro-2H-pyrazol-3-ylamine;4-nitro-2H-pyrazol-3-amine;4-nitro-1(2)H-pyrazol-3-ylamine
Molecular Formula:C3H4N4O2
Molecular Weight:128.08900
HS Code:2933199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:455.5ºC at 760mmHg
Density:1.705g/cm3
Index of Refraction:1.716
PSA:100.52000
Exact Mass:128.03300
LogP:1.00450
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3(5)-Amino-4-nitro-pyrazol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-nitro-1(2)H-pyrazol-3-ylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-nitropyrazole-5-ylamine Use and application,4-nitropyrazole-5-ylamine technical grade,usp/ep/jp grade.
Related News: Taiwan is denying entry to Chinese nationals from Guangdong, a southern coastal province that has also been battered by the virus, and travelers who have recently visited the area. 4-nitro-1H-pyrazol-5-amine manufacturer This part is mainly anti-tumor drugs, prostate drugs and certain hormone drugs. 4-nitro-1H-pyrazol-5-amine supplier In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. 4-nitro-1H-pyrazol-5-amine vendor In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. 4-nitro-1H-pyrazol-5-amine factory This part is mainly anti-tumor drugs, prostate drugs and certain hormone drugs.
